Novo Nordisk aims to hire 1,000 in emerging markets

Novo Nordisk ($NVO) has big hopes for emerging markets--and big plans for hiring enough people to turn those hopes into reality. The Danish company plans to hire 1,000 new employees over the next two years, to carry its diabetes treatments to Colombia, Egypt, Ukraine, Malaysia, Indonesia, and, especially, Vietnam. Report

Suggested Articles

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.

Bluebird has priced gene therapy Zynteglo at €1.575 million in Europe and promised a U.S. price in “reasonably close” range.

Generic pain drug maker Lannett is closing its plant in Wyoming and laying off the remaining 80 employees.